Virios shareholders approve reverse stock split at special meeting

Dogwood Therapeutics, Inc.

Special meeting held March 1, 2024; quorum 64.58% of shares outstanding.
Proposal 1 (reverse stock split) approved with 7,553,703 For vs 4,697,955 Against.
Proposal 2 (adjournment to solicit proxies) approved with 7,778,383 For vs 4,484,974 Against.
No broker non-votes; both proposals passed by required vote.
Reverse split effective date and ratio not disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.